活血化瘀中医干预法对肝硬化营养不良患者的应用效果及血清营养指标影响

摘要/Abstract

摘要： 目的探讨活血化瘀中医干预法对肝硬化营养不良患者的应用效果及血清营养指标影响。方法选取2022年6月—2023年3月甘肃省第二人民医院收治的82例肝硬化营养不良患者作为研究对象,应用随机数表法将其分为观察组与对照组,每组41例。对照组患者采取常规肝硬化治疗和营养干预,观察组在对照组基础上增加活血化瘀中医干预法,对比两组患者治疗前后肝功能指标、营养指标表达水平以及并发症发生情况。结果治疗前,两组患者碱性磷酸酶（ALP）、谷丙转氨酶（ALT）、谷草转氨酶（AST）水平比较,差异无统计学意义（P>0.05）;治疗后,两组患者ALP、ALT和AST水平均降低,且观察组低于对照组,差异有统计学意义（P<0.05）。治疗前,两组患者转铁蛋白（TRF）、前白蛋白（PAB）、血清白蛋白（Alb）和血红蛋白（Hb）等相关营养指标水平比较,差异无统计学意义（P>0.05）;治疗后,两组TRF、PAB、Alb、Hb水平均升高,且观察组高于对照组,差异有统计学意义（P<0.05）。观察组患者肝性脑病、肝肾综合征、消化道出血、感染等并发症发生率明显低于对照组,差异有统计学意义（P<0.05）。结论对肝硬化营养不良患者采取活血化瘀中医干预法治疗能够进一步改善患者肝功能,提升患者血清营养指标水平,降低并发症发生率,值得临床应用。

关键词: 活血化瘀, 肝硬化, 营养不良, 血清营养指标, 肝功能, 并发症

Abstract: Objective To explore the application effect of traditional Chinese medicine intervention method for promoting blood circulation and resolving blood stasis on patients with liver cirrhosis and malnutrition, as well as the impact of serum nutritional indicators. Methods A total of 82 patients with cirrhosis and malnutrition who were admitted to the Second People's Hospital of Gansu Province from June 2022 to March 2023 were selected as the study objects. They were divided into observation group and control group by random number table method, with 41 cases in each group. The control group received conventional treatment of cirrhosis and nutrition intervention, and the observation group was additionally given the traditional Chinese medicine intervention method to promote blood circulation and remove blood stasis. The liver function indexes, nutritional index expression levels and complications of the two groups before and after treatment were compared. Results There was no significant difference in the levels of Alkaline phosphatase (ALP), Glutamic pyruvic transaminase (ALT), Glutamic transaminase (AST) between the two groups of patients before treatment (P>0.05). After treatment, the levels of ALP, ALT, and AST in both groups of patients decreased, and the observation group was lower than the control group (P<0.05). There was no significant difference in the nutritional indicators related to Transferrin (TRF), Prealbumin (PAB), serum albumin (Alb) and hemoglobin (Hb) between the two groups of patients before treatment (P>0.05). After treatment, the levels of TRF, PAB, Alb, and Hb in the treatment two groups increased, and the observation group was higher than the control group (P<0.05). The incidence of complications such as hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, and infection in the observation group was significantly lower than that in the control group (P<0.05). Conclusion The traditional Chinese medicine intervention method of promoting blood circulation and resolving blood stasis can further improve liver function, enhance serum nutritional index levels, and reduce the incidence of complications in patients with liver cirrhosis and malnutrition. It is worthy of clinical application.

Key words: promoting blood circulation and resolving blood stasis, cirrhosis, innutrition, srum nutritional indicators, liver function, complication

中图分类号:

R242

祁喜平, 马蓉霞, 李静, 扈玫琳. 活血化瘀中医干预法对肝硬化营养不良患者的应用效果及血清营养指标影响[J]. 中华养生保健, 2024, 42(5): 23-25.

QI Xi-ping, MA Rong-xia, LI Jing, HU Mei-lin. The Application Effect of Traditional Chinese Medicine Intervention on Promoting Blood Circulation and Resolving Stasis in Patients with Liver Cirrhosis and Malnutrition and the Influence of Serum Nutritional Indicators[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(5): 23-25.

参考文献

[1] 阳宁静,熊亚维,廖佳佳,等.CT直方图纹理参数评价肝硬化与肝硬化合并HIV感染患者腹部脂肪的差异[J].医学临床研究,2023,40(2):268-271.
[2] 刘靓懿,张玲,胡蓉,等.HBV感染相关肝硬化患者外周血线粒体DNA的水平及临床意义[J].国际消化病杂志,2023,43(1):61-65.
[3] 冯瑾,魏绪仓.肝硬化患者骨髓造血系统异常的机制研究进展及其骨髓细胞学检查的临床意义[J].现代检验医学杂志,2023,38(2):200-204.
[4] 黄颖,余小平,陈怡,等.失代偿期肝硬化患者营养不良诊断模型的探讨[J].四川医学,2023,44(2):117-123.
[5] 殷悦,祁兴顺,杨永平.肝硬化患者营养状态的评估及管理[J].解放军医学杂志,2023,48(1):13-17.
[6] 王宇环,李艳梅.肝硬化患者营养不良发生机制及营养风险筛查方法的比较[J].中文科技期刊数据库(全文版)医药卫生,2022(7):39-42.
[7] 张一骏,张茜,罗新华.肝硬化患者营养不良和衰弱的评估与临床管理[J].临床肝胆病杂志,2022,38(7):1646-1649.
[8] 黄国彬,彭薇淇.营养支持疗法联合常规方案对肝硬化合并上消化道出血治疗效果的影响[J].医学理论与实践,2023,36(7):1133-1135.
[9] 王菁华,黄怡寒,金丹英,等.个性化中医营养护理干预对乙型肝炎肝硬化腹水患者腹水消退情况和营养状况的影响[J].检验医学与临床,2023,20(2):261-265.
[10] 中华医学会肝病学分会.肝硬化诊治指南[J].临床肝胆病杂志,2019,35(11):2408-2425.
[11] 中华中医药学会脾胃病分会.肝硬化腹水中医诊疗专家共识意见(2017)[J].临床肝胆病杂志,2017,33(9):1621-1626.
[12] 宋晓婷,许文涛(译),陈煜,等.《2021年美国肝病学会实践指导:肝硬化患者营养不良、衰弱和肌肉减少症》摘译[J].临床肝胆病杂志,2021,37(12):2787-2789.
[13] 张清源,张敬文,吴千言,等.活血化瘀类复方防治高脂血症的临床研究热点与趋势——基于VOSviewer的可视化分析[J].中草药,2022,53(1):196-205.
[14] 来杰锋,傅克模,施维群.施维群教授诊治慢性乙型肝炎肝硬化用药经验的数据挖掘研究[J].中西医结合肝病杂志,2022,32(10):912-915.
[15] 葛舰,李小丹,王祖君,等.基于数据挖掘分析中医药治疗肝硬化腹水与肝硬化顽固性腹水用药规律的异同[J].中西医结合肝病杂志,2022,32(4):347-351.
[16] 陈琳. 基于活血化瘀理论指导下中西医结合护理干预在肝硬化腹水伴营养不良患者中应用[J].辽宁中医药大学学报,2022,24(7):167-170.
[17] 吴英珂,李满,陈辰,等.GLIM标准下3种营养筛查工具对肝硬化患者的适用性分析[J].临床肝胆病杂志,2022,38(2):352-358.
[18] 谢守云,陈素珍,黄丽莹.营养不良的五阶梯治疗在肝硬化失代偿期患者中的应用研究[J].基层医学论坛,2022,26(36):1-3,16.
[19] 张广清,罗利娟,邓燕妹,等.中医特色慢病管理对乙型肝炎肝硬化营养不良患者的影响[J].中西医结合肝病杂志,2021,31(2):120-124.
[20] 王秀静,王晓娟,张雪雪,等.新型全程循环式营养管理在肝硬化腹水伴营养不良患者中的应用[J].内蒙古医学杂志,2022,54(9):1142-1144.
[21] 孙亚娟,袁渊,班凌伟.乙型肝炎肝硬化营养不良患者采用α-酮酸联合低蛋白饮食治疗对营养状态的影响[J].医药论坛杂志,2021,42(16):92-95.